Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients

Table 1 Demographics, therapy and prognosis of esophageal cancer patients

	Total		ESCC		EAC
	n	5Y-SR (%)	n	5Y-SR (%)	n	5Y-SR (%)
Total study cohort	195	27	90	27	105	26
Median age (yr)	60.4	-	60	-	62	-
Gender
Male	155	28	61	25	94	31
Female	40	26	29	32	11	12
Therapy
Surgery only	89	29	32	27	57	31
RTx/CTx + surgery	106	27	58	27	48	28
T-category
pT2	30	46	6	62	24	43
cT/pT3	165	25	84	24	81	26
Endoscopic biopsy	104	25	58	22	46	29

5Y-SR: 5-year survival rate; EAC: Adenocarcinoma of the esophagus; ESCC: Squamous cell carcinoma of the esophagus; pT: Pathologic tumor; cT: Clinical tumor category; RTx/CTx: Neoadjuvant radio-/chemotherapy.